Educational program addresses training gap for practicing endoscopists in minimally invasive EUS procedures to diagnose and stage digestive disorders and diseases
CENTER VALLEY, Pa. and DOWNERS GROVE, Ill., May 16, 2019 /PRNewswire/ — Olympus Corpor… […]
SAN FRANCISCO, May 9, 2019 /PRNewswire/ — Today at the 40th annual Heart Rhythm Scientific Sessions, Acutus Medical announced the agreement to acquire Rhythm Xience, Inc., and new strategic partnerships with Peerbridge Health, Cardiac Designs and M… […]
Enables Expanded Access to the Company’s Portfolio of Tests
SAN DIEGO, April 23, 2019 /PRNewswire/ — Epic Sciences, Inc. announced today that it has received a CE mark for its Liquid Biopsy Test Collection Kit, allowing for sale and distribution of… […]
SAN DIEGO, April 9, 2019 /PRNewswire/ — Mesa Biotech Inc., a privately-held, molecular diagnostic company that has developed an affordable and easy to operate PCR (polymerase chain reaction) testing platform designed specifically for point-of-care … […]
NuVasive Expands Applications of Porous PEEK Surface Technology to Lateral Surgery with First-of-its-Kind Cohere® XLIF Implant
SAN DIEGO, April 1, 2019 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused… […]
– First patients successfully treated with robust integration of technologies- Integrated technologies now commercially available
ST. LOUIS and CARLSBAD, Calif., March 15, 2019 /PRNewswire/ — Stereotaxis (OTCQX: STXS) and Acutus Medical today announ… […]
Saint John’s and John Wayne Cancer Institute to validate use of cerebrospinal fluid with the Company’s Target Selector(TM) assay platform in patients with known or suspected brain metastases
SAN DIEGO, Feb. 27, 2019 /PRNewswire/ — Biocept, Inc. (NAS… […]
Focus on new market segments and strategies to drive growth
SAN DIEGO, Feb. 20, 2019 /PRNewswire/ — Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable informat… […]
Company receives FDA 510(k) clearance and CE mark approval for use of minimally invasive Precice® Bone Transport System to treat segmental bone defects up to 10 centimeters in the tibia and femur
SAN DIEGO, Feb. 19, 2019 /PRNewswire/ — NuVasive, Inc… […]
SAN DIEGO, Feb. 14, 2019 /PRNewswire/ — Decipher Biosciences (formerly GenomeDx Inc.), a leader in the field of urologic cancer genomics, today announced that it will present results from seven studies featuring its Decipher® Prostate and Bladder C… […]
Copyright © 2019 San Diego Biotechnology Network (DBA of Comprendia. LLC)
